PEBF
LIVE

Serial Number

99765783

Owner

Atropos Health, Inc.

Attorney

Thomas Y. Yee

Filing Date

Apr 15, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PEBF Trademark

Serial Number: 99765783

PEBF is a trademark filed by Atropos Health, Inc. on April 15, 2026. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Atropos Health, Inc. (20 trademarks)

169 Madison Avenue, Unit 2242
New York, NY 10016

Entity Type: 03

Trademark Details

Filing Date

April 15, 2026

Registration Date

Not Registered

Goods & Services

Scientific and technological services, including the design, development, and implementation of proprietary study designs and analytical methodologies (e.g., Prognostogram, Pathways) to generate, quantify, and validate large volumes of per-combination precision evidence based findings from real-world data sources; providing non-downloadable computer software platforms for the creation, organization, tagging, and management of internal and external healthcare evidence, including the generation and storage of precision evidence based findings for use in clinical research and analytics; providing curated, personalized, and cited evidence in the form of precision evidence based findings, including individual statistical findings for specific intervention-baseline-outcome combinations, specifically designed as primary training material to inform and benchmark large language models (LLMs) and artificial intelligence (AI) in the healthcare domain

Electronic transmission of data, documents, and digital content, specifically personalized precision evidence based findings to facilitate shared decision-making, provider care assistance, and commercial and brand planning; providing telecommunications access to a proprietary library and database of novel studies and precision evidence based findings for both human and automated consumption, including the provision of application programming interfaces (APIs) for data access

Providing business consulting, management, and administrative services in the healthcare industry, utilizing precision evidence based findings for strategic planning, operational efficiency, and evidence-based decision-making for healthcare providers, payers, and pharmaceutical companies; providing business intelligence and predictive data analysis services, including content creation and market share analysis, using precision evidence based findings to inform formulary guidance, medical benefit positions, and commercial and brand planning; business advisory services focused on healthcare cost containment, precision adjudication of high-cost therapies, and streamlining prior authorization processes by applying granular, personalized evidence-based findings quantifying outcomes for specific combinations of clinical interventions, patient baselines, and health outcomes

Providing medical and clinical information services, including the surfacing and delivery of precision evidence based findings relevant to an individual patient's clinical profile to inform personalized medicine, patient risk stratification, and patient care decisions at the point of care; providing health outcome and medical analysis services, including the quantification of risk and the monitoring of outcomes per case, based on precision evidence based findings to support providers, payers, and patients

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 15, 2026 MAFR
NEW APPLICATION ENTERED
Apr 15, 2026 NWAP